URGO Apósito Spray
Commercial- Indications
- Wound care
Company intelligence / Profile preview
TervisPharma is a Chilean pharmaceutical and medical device company focused on the development, intermediation, and commercialization of health and wellness solutions. As a member of Grupo Nutraline, the company specializes in importing and distributing high-quality finished dosage forms, medical devices, and nutraceuticals from international partners. Their diverse portfolio includes specialized products for ophthalmology, wound care, nasal hygiene, and nutritional supplementation. TervisPharma maintains in-house departments for regulatory affairs, marketing, and logistics to ensure comprehensive service for patients and healthcare institutions across Chile. The company prides itself on strategic global partnerships and a commitment to delivering innovative therapeutic options to the local market.
11 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TervisPharma.